Comment
doi: 10.1038/mt.2010.41.
AAV provides an alternative for gene therapy of the peripheral sensory nervous system
Affiliations
- PMID: 20357781
- PMCID: PMC2862524
- DOI: 10.1038/mt.2010.41
Item in Clipboard
Comment
AAV provides an alternative for gene therapy of the peripheral sensory nervous system
Mol Ther.
2010 Apr.
No abstract available
Comment on
-
Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.Mol Ther. 2010 Apr;18(4):715-24. doi: 10.1038/mt.2010.19. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179682 Free PMC article.
Similar articles
-
Crossing the blood-brain barrier with AAV vectors.Metab Brain Dis. 2021 Jan;36(1):45-52. doi: 10.1007/s11011-020-00630-2. Epub 2020 Nov 17. Metab Brain Dis. 2021. PMID: 33201426 Review.
-
Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases.Gastroenterol Clin North Am. 2019 Jun;48(2):319-330. doi: 10.1016/j.gtc.2019.02.005. Epub 2019 Apr 1. Gastroenterol Clin North Am. 2019. PMID: 31046978 Free PMC article. Review.
-
AAV: An Overview of Unanswered Questions.Hum Gene Ther. 2017 Apr;28(4):308-313. doi: 10.1089/hum.2017.048. Hum Gene Ther. 2017. PMID: 28335618 Free PMC article. Review.
-
Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.Life Sci. 2021 Apr 1;270:119142. doi: 10.1016/j.lfs.2021.119142. Epub 2021 Jan 30. Life Sci. 2021. PMID: 33524419 Review.
-
Vectrology of adeno-associated viruses (AAV).Med Wieku Rozwoj. 2013 Jul-Sep;17(3):202-6. Med Wieku Rozwoj. 2013. PMID: 24296444 Review.
Cited by
-
Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats.PLoS One. 2013 Apr 16;8(4):e61266. doi: 10.1371/journal.pone.0061266. Print 2013. PLoS One. 2013. PMID: 23613824 Free PMC article.
-
Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons.Mol Cell Neurosci. 2014 May;60:72-80. doi: 10.1016/j.mcn.2014.04.004. Epub 2014 Apr 24. Mol Cell Neurosci. 2014. PMID: 24769104 Free PMC article.
-
Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief.ACS Pharmacol Transl Sci. 2024 Jun 6;7(7):1916-1936. doi: 10.1021/acsptsci.4c00181. eCollection 2024 Jul 12. ACS Pharmacol Transl Sci. 2024. PMID: 39022365 Free PMC article. Review.
-
AAV-Mediated Gene Transfer to Dorsal Root Ganglion.Methods Mol Biol. 2016;1382:251-61. doi: 10.1007/978-1-4939-3271-9_18. Methods Mol Biol. 2016. PMID: 26611592 Free PMC article.
-
Virus-mediated shRNA knockdown of Na(v)1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic pain.Mol Ther. 2013 Jan;21(1):49-56. doi: 10.1038/mt.2012.169. Epub 2012 Aug 21. Mol Ther. 2013. PMID: 22910296 Free PMC article.
References
-
- Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freese A, et al. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther. 2002;13:1391–1412. - PubMed
-
- Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 2007;369:2097–2105. - PubMed
-
- Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, et al. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology. 2008;70:1980–1983. - PubMed
-
- Marks WJ, Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 2008;7:400–408. - PubMed
-
- Worgall S, Sondhi D, Hackett NR, Kosofsky B, Kekatpure MV, Neyzi N, et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum Gene Ther. 2008;19:463–474. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
